Latest / Age Defiantly with Mark Young / Why Everyone's Using GLPs Wrong with Dr. Melissa Grill-Petersen

Transcript

Why Everyone's Using GLPs Wrong with Dr. Melissa Grill-Petersen · Age Defiantly with Mark Young

• 0:00
  I'm going to be the first person to tell you that agents optional and genes are not your destiny, not even a little bit.
• 0:04
  12 to 13% of the entire U.S. population living on the GLP and that's not just people with occasional use.
• 0:10
  That's extended time users. Those are people that are using them for three months or more.
• 0:14
  And we're all just willingly happy to buy it from an influencer. We're not questioning where it's coming from.
• 0:19
  What's really in it? Who's looked at it? How's it inspected? How do I mix it? How much do I actually take?
• 0:24
  Probably one of the most frightening things that I'm seeing right now is that people who are on GLP ones are now experiencing that same pleasure center that's able to suppress addiction or able to suppress gambling or whatever is suppressing intimacy.
• 0:38
  Divorce rates amongst GLP users are going up and you're not wrong. And here's the thing.
• 0:43
  So longevity conversation has been happening for decades, blue zones, caloric restriction, teal and mirror length, NAD, the usual suspects. We're all familiar with it.
• 0:56
  But what's different now and what my guests today has spent 25 years building to work is that shift from longevity as theory to longevity as clinical practice.
• 1:08
  Now, from talking about living longer to actually doing something about it, she's focusing in on it as a molecular level. Dr. Melissa grill Peterson is the co founder and CEO of peptide university, the founder of human longevity global and the head faculty for the human longevity institute.
• 1:27
  She's trained thousands of clinicians worldwide in peptide therapy and precision health. She's a TEDx speaker, a best selling author of the codes of longevity book and the pioneer of the bio house span framework, a systems level model for what it actually means to thrive at every age.
• 1:48
  So she also lives what she teaches as her biological age, she says is 13 years younger than her chronological age.
• 1:57
  She's one of the foremost voices on peptides, women's longevity and the future of precision medicine. And this is a conversation that's going to cover all three of those things.
• 2:07
  Dr. Melissa grill Peterson, welcome to age to finally.
• 2:14
  So great to be here.
• 2:15
  My gosh, it's so cool. And I was just saying before we got here, like I'd know you forever. Yeah, like so long I can't remember how we'd met. Yeah, I mentioned before, and I can't believe we'd never actually sat down and had conversations like his office, and now like so fine.
• 2:28
  I said, the last time I saw you before this weekend, we were partying a diplo concert.
• 2:34
  And it was so much fun. Yeah, but great night.
• 2:37
  We were literally, this is what happens.
• 2:38
  And if you don't know when all of the practitioners did together, apnecical conventions, you end up at a diplo concert.
• 2:45
  She's totally I'm well, I had to lack because even when we were at that, that concert, and I chuckled because I'm looking around at who knows who's at these things, right?
• 2:53
  And like, how many people would look around and guess the credentials that you were sitting at our table, exactly.
• 3:02
  And I do remember less one dude came up and he's like, I would remember how he found out that we were doctors.
• 3:09
  And I like, there was an anesthesiologist. There's a neurosurgeon. There's a cause like there's all these to your point.
• 3:15
  There was all these credentials. And he was like, no, wait, like you guys are the cool. I want you bad dream.
• 3:22
  My doctors are like, well, no, you can't.
• 3:26
  But there's us. It's so funny. And so true though, because like, here's all of us that are at this, at this area where they for him, I'll be lost,
• 3:35
  made us, right? And then the next thing, you know, we end up Dave ends up booking private tables and we all end up with a concert.
• 3:41
  And I'm like, what is happening? And by the way, I got to tell you, you wouldn't make it the last years.
• 3:46
  I didn't even come with us. I know for the speak easy. I was supposed to.
• 3:51
  Well, it's so we actually went to kind of offer after nothing to do with this, but it's an endorsement.
• 3:56
  It's a good story. Have you been to the pinky ring?
• 3:58
  No, like I wanted to go. It is like Bruno Mars bar in the Bellagio. And we went there this year.
• 4:06
  Like, I love it. Yeah. What a cool. I will hide for it and everything.
• 4:11
  Like, but I got so tanked at the end of that day. I was like, yeah, it's my gosh.
• 4:15
  I even thought it cool. It's not our though. And I mean, we went there and hung out and mean all the usual suspects.
• 4:22
  Yeah, hopefully a few extras. But the music was amazing. And then what's funny is that
• 4:27
  Bruno Mars just came out with a new album, which anybody's now listened to it.
• 4:32
  100% recommended every single song. And that album is amazing.
• 4:36
  And literally and in one of the songs, one of the lyrics is there's a party at the pinky
• 4:41
  ring. And I'm like, I've been there. So every time I listen to this, I think of all the pinky
• 4:48
  ring and the Vegas party last year. It was so much fun. But it's so fun because I say that I'm
• 4:55
  spoiled. And I never want to take it for granted because the space that we get to thrive in is
• 5:03
  just filled with so many amazing people. And it's not all shop. It's fun too. But what I find
• 5:09
  amazing about it is there's nothing that can go on in my life that I don't know an expert in the
• 5:16
  field that I can call. Yeah. And it's I'm spoiled because I'm literally talking to the foremost
• 5:22
  authorities on topics as does the host of a podcast, right? That I pick up the phone and make a
• 5:27
  phone call and and did an expert on the line. And in people that I can literally call on the
• 5:32
  moment's notice and just say, Hey, I'm having a problem. What do you recommend? Right? Like,
• 5:35
  Hey, I need this. What can you do? And it doesn't it doesn't get lost on me that the rest of the
• 5:41
  population. There's so many people who just don't have that. And you know, when something comes up,
• 5:48
  whether it's my health or a friend's health, like, you know, this, you're the phone call that people
• 5:52
  make. They call you and say, Hey, what's going on? How can you help me? And you immediately
• 5:56
  jump to action and make your calls and do your things. But platforms like this and platforms
• 6:03
  like yours, peptide university and also your global summits that you're running, like,
• 6:09
  it's the education that allows us to mass media that type of information out. So like, the world
• 6:15
  doesn't have your phone number. Right. But they can have your information. Yeah. That that you
• 6:21
  educate and you're training them and you're getting them as much information as they need. And the
• 6:26
  truth is is, you know, in a conversation I was having on a podcast earlier, we were talking about
• 6:30
  there's no shortage of knowledge in the world anymore. But what I, what I need is to talk to the
• 6:36
  experts because we're still lacking the wisdom on how to apply that knowledge. Yes. Absolutely.
• 6:42
  And you know, what you were just alluding to, one of the things that we have, and I think about
• 6:47
  it often, because when I come to the events, you know, we work our high knees off. It's, it's a lot
• 6:52
  we show up and we give fully to educate the other leaders that are boots on the ground in the field
• 6:57
  working with patients every single day. But I get so excited. It's something I get to just be with
• 7:03
  my favorite cuens, my best best brows. And we have such what we have is true tribe, true community,
• 7:13
  deep connection. And it's not just shared interests. It's there's such a, I think especially in
• 7:19
  this realm, we look at just, I call it health care 3.0, how, how health is evolving, whether
• 7:24
  people want it to or not, or it's not even about functional, it's not, it is a whole integrative
• 7:29
  model that is coming to the surface that is a mix of alopathic, right, as well as foundational
• 7:36
  and functional and regenerative. And it's like, what does it mean? We're not just siloed,
• 7:40
  and it's not just one dogma. And so it's like, how do we all play nice together? But when I look at
• 7:46
  this evolution and a really interesting way that it's bringing different lanes of health care
• 7:51
  from again, alopathic to alternative to together. And that's just the GLP conversation in and of
• 7:57
  itself and what that is doing, which and we'll dive into that today. But my point being is that
• 8:05
  the ability to come together, everybody here is mission driven. So we're showing up with heart
• 8:12
  centered desire and care and and contribution. And I think to your point, it's not only in everyday
• 8:19
  life, do we not have the role of decks of all the numbers with the people with all the answers.
• 8:25
  But we really don't have the level of connection. I think we're, we're pretty spoiled and yet it's
• 8:32
  it's a fundamental driver of longevity. Like that is one of the biggest proponents of what's
• 8:39
  going to keep us living longer better because it means somebody cares worse. It means how a
• 8:45
  reason to get on better. Well, that's the number one thing that they see makes blue zones,
• 8:49
  blue zones is the sense of community that they have within that that people there have that
• 8:53
  natural connection. And I argue we say connection and purpose. Yeah. And this entire buildings,
• 8:59
  but it is is nothing but purpose. We're at the change in life destiny conference right now. I'll
• 9:04
  in Plano, Texas and everybody here is purposed. And usually the community builds as far as I see it,
• 9:12
  because I can walk through them the vendor hall and know half the people that are there already.
• 9:17
  Hey, and I know their purpose is open burst from pain. Yeah. That there's been a struggle.
• 9:22
  There's been that the hero story in every one of those eight by eight booths has some hero
• 9:28
  story in there. It was a this life was normal. Then this happened. Then the struggle did defeat
• 9:35
  and ultimately what I found was and I say it's like playing madlibs with yeah with vendor brands
• 9:41
  because I literally just go in the mix that the story is the same like the same story arc exist.
• 9:47
  It was you know, I had cancer. They told me I had six months to live. I got deep. And this is
• 9:52
  what I found. And now I want to bring this to the world. It's the same story art takes place.
• 9:58
  And I think that's where that community builds is through shared origin stories and a lot of
• 10:03
  reason appreciate that. And you know, it's interesting because I'm saying going that's not my path.
• 10:08
  And and it's like I'm looking at going hmm that and there's so much truth to what you're saying
• 10:12
  because and there's not a right or wrong to any of it. It's so beautiful. But I you know,
• 10:17
  I have been called and I would say so, especially if anybody ever listens to like human design,
• 10:22
  I'm what's called a projector, but just the way my marrying was try your okay, you're on each end.
• 10:26
  Great. So so the way but how the way my brain works and always has is I'm a system of stinker.
• 10:32
  Big picture I can see macro and micro, but I see the opportunities. So I see the holes in the gaps
• 10:38
  as well as the opportunity. And so and I somehow however it was designed, I really don't I've
• 10:45
  sat and thought about this at length at times going like how can I have a lot of adversity,
• 10:50
  a lot of things that were not easy and uncomfortable at trauma, all the things growing up. And I'm like,
• 10:55
  the how did I somehow find the way I just going, I'm not going to believe I like from a young age,
• 11:00
  I was like, I'm not believing that limited story. Like just my brain was like, that doesn't
• 11:03
  make sense to me. So it was interesting. As far as longevity, you know, I'm Italian heritage and
• 11:11
  I'll never forget as a kid. I mean, like I don't even know if I was 10 years old. I was sitting around,
• 11:15
  it was a Sunday afternoon and you know, Italian families that get together on Sunday and we manjo,
• 11:19
  we eat a lot of good food and they play poker and they smoke and they joke and they like, you
• 11:24
  know, it's loud and it's boisterous and they're they're doing the things. And I'm a kid and I'm
• 11:29
  just looking at it and I'm looking at all of my relatives into me. They're just beautiful. I mean,
• 11:33
  they're they're again gorgeous skin like my great aunts and I'm like, look at that full out of
• 11:39
  hair. Look at that skin. Like I'm like 10 year old. I know why I'm thinking about this. I can't
• 11:44
  say that I knew anywhere else, but I literally have these thoughts. I'm just like, and don't ask me
• 11:49
  where I also heard this back in the early days. I'm like, I'm going to live a long time. I've got
• 11:55
  good genes. Yeah, which I break kids. I don't know where that came from. However, what the
• 12:03
  rub is is that, you know, I'm going to be the first person to tell you the aging's optional and
• 12:09
  genes are not your destiny, not even a little bit. So my first educational partnership and
• 12:14
  brand that I was that I helped to build was an epigenetic coaching academy. And so really understanding
• 12:20
  the quality of the input, the signals. What's really informing? So, okay, yeah, our genes, but no,
• 12:25
  we know all look at the blue zones. Not everybody there was a long right old life at all, right?
• 12:30
  There are outliers and there's a lot that we can learn from pattern recognition and we can see
• 12:35
  well, this population overall trends better than America or, you know, so so we can look and say
• 12:44
  this trends better than we can see patterns. And yet, there are still a lot of people there that
• 12:49
  don't live to centenarians. They don't let like they have art attacks in their 50s. And also,
• 12:54
  it's kind of like, okay. And so it is that same story just because we have the SNP, just because
• 13:00
  we have the DNA doesn't mean that it actually expresses in a way to mean disease or even flourishing.
• 13:07
  So what what makes one person different than the other? Well, it's the quality of the input.
• 13:11
  What's coming in and informing that human system, right? It override genetics. Complet well,
• 13:18
  it's it is yes, you work with it. So you're either you have a blueprint that is true. But what's
• 13:23
  going to make it express or repress, right? So am I playing to my strengths or my weaknesses?
• 13:27
  Easy way to think about it. And that's what we have. That's that's what's malleable. That's
• 13:31
  what we have access to go, okay, I'm going to do more of what lets me be my best version of me.
• 13:36
  And the places where I could have some risks, I'm going to do risk a version like let me go ahead
• 13:41
  and minimize those risks and not playing to that. For example, I do that a higher propensity
• 13:47
  to naturally fall into the category. Let everybody let's talk APO. Let's talk. Let our why can't I
• 13:54
  think I can't get my words out right now, long of the end of the day. APO before, okay, APO.
• 14:00
  Get a four, snip. Oh my gosh, all summers. Oh my gosh. Oh my gosh. Oh my gosh. That is not
• 14:06
  the case. Just because you have that, if you have a four allele, you are at a risk that if you
• 14:14
  eat higher saturated fat, you have a higher pro and climatory diet, higher levels of stress,
• 14:22
  higher circadian disruption, all the pro and climatory things, then yes, you are absolutely at a
• 14:28
  much greater risk that you will absolutely express that. Well, and then again, it's mitigating
• 14:34
  risk factors. It's not about overriding per se because it doesn't mean that if you do everything
• 14:39
  right, it's not going to still express because it may. Yes. Like mitigating risk factors is obviously
• 14:46
  a thing. It's plugging the biggest poles in the dam first. Yeah, but guess what? I have a four allele,
• 14:51
  I have a two four and I still use saturated fat. It's not just about saturated fat. It's okay,
• 14:59
  how much is it, but it's what are all the other pro and plumbatory things. So just by exercising,
• 15:03
  I'm already reducing my risk more than somebody who's got the four and doesn't eat saturated fat.
• 15:09
  So again, it's like there are nuances to this, right? And so where I'm going with the it's not
• 15:13
  always so much pain as human beings. We are driven by pleasure or pain. That is what we are.
• 15:19
  We are emotional creatures. And so of course, many of us have an origin of I got to get sick
• 15:24
  and tired of being sick and tired. It's got to be so bad. That's it. Then now and usually that
• 15:29
  that's the precipice of growth. And that's beautiful. Hence all the vendors, hence why we're all
• 15:33
  here in a shared mission. And yet somewhere along the line for me, I kept looking at it and again,
• 15:39
  just kind of going, okay, okay. And even like going through trauma, all of it, the first time I
• 15:45
  went to a therapist and they're trying to tell me like, that doesn't make a bit of sense to me.
• 15:48
  And I'm like, I want to look for like there's just so it's kind of what is what is good?
• 15:54
  Like what's the reason for now? Let me focus on the problem and try to escape the pain.
• 15:58
  Well, and I want to hear up there real quick. Yeah. Because I love where you're going with that.
• 16:03
  And I want to from a clinical standpoint. So from a psychological clinical standpoint,
• 16:08
  you're saying, well, that therapist that didn't make sense to me because I want to go in this direction,
• 16:12
  not this direction. But it if I can be the contrarian and say, of course, yeah.
• 16:18
  Like epigenetic expression. Yeah. That pathway may have worked for somebody else.
• 16:24
  Of course. Who actually wanted that? It's for you to decide that this path is not going to work
• 16:28
  for me at all of it is choice. Correct. It is literally the matching the pieces together so that
• 16:34
  they actually, you know, interwatch the way they should. And that is if you're at risk,
• 16:40
  create, make these choice and yeah, or make this choice pick one. Yeah. But you can, yeah,
• 16:45
  less saturated fats or exercise this or or both. But the reality is like the same thing with with
• 16:53
  trauma, the same like there are some people that, you know, one thing works and another doesn't.
• 16:57
  And what I want to unpack and what we've been actually, it's funny because the common theme
• 17:02
  that I've seen the story arc throughout this entire conference with everyone I've been talking
• 17:06
  to has been this non-stop conversation about integration and uniqueness about everybody's
• 17:13
  different and having to deal with there is no one size fits all solution. And we can't bang
• 17:18
  one brum and think that everybody falls in line, right? I love that. And I love that you're dealing
• 17:25
  with peptides specifically. If I can pivot us a little bit in that ration. Sorry. We're like going
• 17:29
  down. So you're good. You're good. Party in and personal destinies. Hold on.
• 17:35
  But the reason I bring that up is because people are looking and again, this uniqueness,
• 17:42
  this this epigenetic expression, like peptides plays a role in all of that too because I see
• 17:48
  these social media posts, you know, bro, here's my peptide stack. You should try this. And it's
• 17:54
  like, no, you don't know what someone else is. And the most common thing, and I want you to
• 18:00
  comment on this really hard for me because we get to phone calls from everybody else in our lives.
• 18:04
  So what should I be taking? And you know, I said it a hundred times on this podcast, but it's like
• 18:10
  my response typically, I don't know your physiology. And I can't answer that question for you. And
• 18:16
  I typically start in the, well, let's talk about what you can be taking away first because we can
• 18:21
  safely take anything away. Yeah. So let's let's talk about what are the things that you shouldn't
• 18:26
  be doing or shouldn't be consuming or whatever. But until I had a very clear picture of who you are,
• 18:32
  it's irresponsible for me to make recommendations to you. And peptides are no different, right? Because
• 18:39
  everybody's given it by some peptides nowadays. And yeah, I'm happy that the government is lifting
• 18:46
  the restrictions that we're recently put on. And I'm happy to see that we're opening those
• 18:51
  channels again. Because as you know, painfully well, like last year became a real monumental year
• 18:58
  or peptide restrictions. So he's okay. We're opening some of that up. We're opening psychedelics
• 19:03
  now where we're offering different things to the masses. I'm happy it's becoming available. And
• 19:09
  I'm also at the same time scared because it's also going to open up people being able to use
• 19:16
  things without the type of advice or diagnostic tools that they should be using first. Yes,
• 19:21
  and no. And don't mean here's and here's why. So because of what happened really over the last
• 19:28
  couple of years after things were recategorized and the boom of the research use only market.
• 19:35
  And the fact that there was a over a hundred billion dollars generated in that market.
• 19:41
  And so you take that away from pharma. That's that's that's a thing. But also it's a hundred
• 19:48
  billion dollars of unregulated, unregulated API that's going into somebody's body. And we're all
• 19:56
  just willing, nearly happy to buy it from an influencer. We're not questioning where it's coming
• 20:00
  from. What's really in it? Who's looked at it? How's it infected? How do I make say how much
• 20:04
  do I actually take? Like what people and it's become so trendy people do not understand the lay
• 20:11
  person doesn't understand that these are actually very powerful molecules. They are their medicines.
• 20:17
  They work on very powerful pathways within the body. They work on some of the most critical
• 20:25
  like signaling components and tissues and receptor sites that are dealing with everything from
• 20:31
  repair, rejuvenation to literally again, how insulin is being signal, how growth factor is being
• 20:38
  released. You know, how your BDNF and your brain is being activated or repressively,
• 20:44
  there's so many functions that these molecules do and what the average person doesn't understand
• 20:50
  because it's just very popular. And while it was over the past couple of years very unregulated,
• 20:55
  anybody could go out and make any claim. There was no repercussions. They made a boat load of money.
• 21:01
  A lot of people either spent a lot of money, got zero results, spent a lot of money, got maybe
• 21:06
  medium results, spent money, maybe ended up in the hospital. I can't tell you how many stories I've
• 21:11
  heard of people in the hospital. And take it from the overuse of GLP and then end up with gastritis
• 21:17
  and not just GLP. Actually, I literally was talking to somebody today like she's like, well,
• 21:21
  I went into this doctor and he put me on CJC from Rellen and I had an immediate, you know,
• 21:26
  allergic response. So I went in, she's like, and then I went to another doctor, like ex-month later
• 21:31
  and he put me on and I told him what was going to happen. I told him what happened before. So like
• 21:35
  as soon as that started, he took me off that, he put me on test morale and I landed in the emergency
• 21:39
  room because the practitioner wasn't listening. First of all, anybody that's listening and watching
• 21:45
  this, I'm going to say that if you are not certified and you're doing anything with peptides,
• 21:49
  you better stop doing something if you don't know what you're doing so you better get certified.
• 21:52
  And it's not a joke because like these are not supplements. They're not a supplement. They're
• 21:57
  not just a fight. They're not a water soluble B vitamin that you can drink a left water and pass
• 22:02
  it out of your system. These are cell signaling molecules. They're amino acids and we think, oh,
• 22:07
  amino acids is a protein shake. That's natural. Yes, they're natural, but they're code. Now we
• 22:12
  come back to DNA. People do not understand that peptides are literally sequence of information
• 22:17
  that are literally instructions in the body to say, do more of this, do less of this, start, stop,
• 22:23
  more, less. Like it's like very, very specific instruction. And you're talking like proteins with
• 22:30
  the building blocks of everything in your body and you're injecting amino acids which are the
• 22:34
  building blocks of proteins. There's a back door chain amino acids that are literally
• 22:40
  creating proteins in your body. So something functions more than it did or less than it did and
• 22:45
  you're you're manipulating. Yes, proteins in your body and the proteins are being driven by the
• 22:50
  DNA as you're saying. Like these are the codes and that coding the body. And yes, you're adding
• 22:56
  things that don't belong to trigger things the way that we want them to. It's very manipulative to
• 23:01
  the system. Right. And yeah. And now you add on core quality and sourcing them. Most of you know,
• 23:07
  I mean, I know you have this conversation with others before like not and stuff like that,
• 23:10
  but the reality is the exhibits alone in these bottle, the level of purity. Like the there's
• 23:15
  just so there are so many things that were coming out of that research space that really were just
• 23:21
  causing a lot of problems. We'll just keep it simple like that. So I think what's great about
• 23:26
  the regulation. You're great about the rig hat, agarization, the reassessment. But it doesn't mean
• 23:31
  open doors actually means tighter gatekeeping. So research use is getting is and so the you know,
• 23:38
  my peptide university.com we are the approved educational body of the American peptide association.
• 23:43
  And so we're on calls with them all the time. I sit on the board. We're always at the forefront
• 23:48
  of what's happening legally. So any of these four research only, which has been kind of the direct
• 23:53
  to consumer. Most of them are a lot of them are going to go away in the hands that stick around.
• 23:58
  Let me clarify to the audience that is for research only peptides is the way that we that you've
• 24:03
  been able to buy them through places like peptide sciences and stuff like that once you close their door.
• 24:07
  Correct. And peptide sciences you literally just one day their website is down and no one knew what
• 24:12
  happened because they were under so much scrutiny for what they were doing. Not saying they were good
• 24:16
  or bad or whatever, but so many of these places they sell them for research only not for human use,
• 24:23
  which we all know is a wink wink nod nod to use a girl risk. Correct. Correct. And so now I think
• 24:31
  you know what is what it is going to take a minute. I project at least 18 months, but there's
• 24:36
  so much happening right now even as we speak like so many accounts on social media are getting flagged.
• 24:41
  You know, there's so much shadow banning everything around peptides because again,
• 24:45
  and I think what people need to understand is pharma is here to stay with peptides.
• 24:50
  Like what they've done with GLPs, they're going to do it again and again and again.
• 24:53
  And so basically the moving the recategorization is saying, hey, I mean GLPs are going to be $100
• 25:02
  billion of an industry, $100 billion in just GLPs.
• 25:07
  Well, in GLPs right now, they're what is the latest statistic I saw that 12 or 13% of the entire
• 25:13
  US population is out in GLP went out of every eight people, which is insane. Like 12, 13 was 12
• 25:21
  points, something percent of populations living on the GLP and that's not just people with occasional
• 25:26
  use. That's extended time users. Those are people that are using them for three months or more.
• 25:31
  12 to 13% of the entire US population. And it's like, if that much of the population is doing
• 25:37
  something that I agree with some form of regulation, don't know that I agree with Lily Pharmaceutical
• 25:42
  being the one, two. No, no. And I'm not saying I'm not saying I'm in agreement. What I wanted to
• 25:48
  clarify that point is where I'm going with it is what they did with GLPs. They're going to be doing
• 25:52
  with a lot of other peptides. And so it's for people to understand they're here to stay, but they're
• 25:56
  saying, hey, this is our superstar. We want this. This is our cash cow. We'll give you guys some
• 26:03
  of this. So we'll play together. We're going to play and there's going to be oversight and there's
• 26:07
  going to be regulation. And we're going to clean it up. And the one thing that this
• 26:11
  Relator agencies do really well for us is they do say, you know what? These are human beings at
• 26:15
  the end of the day using this stuff. And I think the one thing we can all agree on is what has happened
• 26:19
  over the last few years is it has been the wild wild last and it has been a, it's been a crap show.
• 26:24
  It really has been and it's in its unfortunate because they, but at the same time, I think it's great
• 26:30
  because now it's forced our hand and we're like, no better do better. And the industry is going to
• 26:34
  get cleaned up and it's going to continue to get cleaned up. There will be more regulation. There
• 26:38
  will be more guidelines. But there's, so what we teach inside the Captain University, there's
• 26:42
  really a feist of access ladder. So are you always going to go away less and less and less? And
• 26:47
  really what's happening is that to access peptides, you will be accessing it through a clinician.
• 26:52
  So it will be clinician led. It will be clinician clinical oversight to it. Hence why,
• 26:58
  if somebody is in the space and they've been thinking they're just learning from an influencer
• 27:02
  even chat, there's no discernment on chat. Chat does not actually understand what's really going
• 27:07
  on in the clinical picture. And so they don't, it's not just about the molecule at all. And so we
• 27:14
  teach an entire clinical framework, but you have to understand how to think about these things
• 27:18
  because you don't get on them stay on. You're not supposed to get on a GLP and just say on a GLP
• 27:22
  at all. Again, these things they work, they are cell signaling. Most of the time with the GLP
• 27:29
  as an exception, they last for minutes, minutes within the body. Okay, so they're done in
• 27:33
  pulsatile fashion. They're done for very specific outcomes. They're part of very specific care
• 27:38
  plans. It's always for what reason. So you said, hey, when somebody comes to you and says,
• 27:42
  what should I take? It's like, well, why are you even asking that? Meaning for what reason? What
• 27:46
  is it that you are really thinking you want to do for yourself? Because we understand where
• 27:50
  they're minus set. They've been intent about. Right. And it's not like over all the years.
• 27:55
  And look, I've done all of it. I did, I did the hardcore functional medicine practices and all
• 28:00
  the elimination. You do all the things you can't do, shouldn't do, won't do, won't do. And like
• 28:04
  the reality is, is you try living that life. Unless you're really chronically sick, which you'll
• 28:08
  do for a minute, all of a sudden, you, you become all of its identity based. So now it's more of what
• 28:14
  I shouldn't do, shouldn't do, can't do, can't do more restriction, more restriction, more restriction
• 28:18
  and limitation, which in and of itself become distresser. So we really think of what's driving
• 28:22
  aging. We think about what's driving chronic disease and metabolic disorientation and everything
• 28:27
  else. The race in response, it is what is happening in the autonomic nervous system. So when we are
• 28:32
  in this constant sympathetic drive, we can't modulate and recover and toggle over to parasympathetic,
• 28:38
  we're in a fight or flight. And we are constantly dripping cortisol. And we're constantly dumping glucose.
• 28:42
  And we are constantly dysregulating insulin sensitivity. And that is what just makes it
• 28:49
  as Jay Campbell says, a dumpster fire all the way downstream from below that because that drives
• 28:55
  that's 80% of what's going to drive everything else going on through the system. But
• 28:59
  so now we start, we're pro inflammatory. Now we are breaking down the cells and the receptor
• 29:04
  site. So when we are in this dysfunctional state and we take these molecules, the train isn't
• 29:10
  prepped. We haven't lifted the signal. So it's not so much about don't do this, don't do that
• 29:14
  eliminated all is saying, what are we really trying to do? Where are we starting?
• 29:18
  Well, it's with me. I've jumped in. It's like most people, you and I are missing a more about
• 29:23
  especially you, peptides, it can name all fancy names and all the other good stuff. But for most
• 29:28
  people, I would say general general population, they're, they're, they're most familiar with G.O.P's
• 29:33
  thirst. And I love G.O.P's sick. Like, I specifically using run a true tag right now,
• 29:38
  yet I want to try and see what goes on. But in some of that is because I'm my own science project
• 29:42
  in some respect. But I also know how to titrate it and deal with it. But people are familiar with
• 29:47
  that. They're probably from the earth like G.H.A.C.U. You know, because that's, you know, peptide
• 29:51
  additive and a lot of skincare and stuff. Yeah, which is just copper. Yeah.
• 29:55
  People are used to that kind of stuff. I think maybe some of the amateur hackers are from
• 29:59
  there with like Molina Tantu and stuff like that. There's some of that that people have a
• 30:03
  little bit of a general audience to G.B. Maybe T.B. 500 BPC 157 kind of stuff. If they're really
• 30:10
  trying to dig a little bit deeper, maybe C.J.C. in the body, dirty crowd, but G.O.P's.
• 30:15
  Sure. That's the population. The population understands G.H.K.C.U. maybe for skincare. But G.O.P's,
• 30:21
  I think everybody understands now. It's everywhere. It is super bowl commercials. It is literally at
• 30:28
  that forefront of the of the story. What is your opinion of this just pervasive use of G.O.P's?
• 30:37
  Because let's be honest, most of it's not getting prescribed. Like, it's not just the
• 30:42
  ozempic pen anymore. We're talking ozempic, manjaro, we're talking semeglotide, redotruthide,
• 30:49
  terzepetide. There's so many of them out there and they all have different activations. But
• 30:56
  what is your opinion? Like, we've got a population. My wife, I kind of chuckle about it because I'm
• 31:01
  like, you know, we had a whole conversation about body positivity, right? It until G.A.P. was
• 31:05
  ramble. Now we're getting wants to be skiing again. Yeah, now we're about to hear a little
• 31:08
  shake. Exactly. Exactly. Like, everybody wanted body positivity until there was a shortcut.
• 31:13
  Yeah. That's it. Now we're getting wants to be thin again. Yeah. So I kind of laugh. I'm like,
• 31:18
  wait a minute. Why do I thought everybody liked being fat? But what is your opinion of the G.O.P.
• 31:22
  market right now, truthfully? And I don't want you to go into peptide university mode,
• 31:27
  but I want you to be in like, you're human. Yeah. No. Again, I am, I am happy to talk. This is
• 31:34
  not just a branded statement. So, so let's pull back for just a moment. And, you know, you were
• 31:38
  making the sharing the stat earlier, which was accurate that 12, about 12% of the population is
• 31:43
  currently on these molecules. But here's the more staggering stat is that 93% of the population
• 31:50
  has men ball at this portion. Yes. 93%. Yes. Okay. So nine out of 10 people, basically,
• 31:59
  will end up being honest, could benefit from these should be honest to an accept. And I'm not saying
• 32:04
  the real issue that we have isn't the molecule. It's for sure. The dose. It is the dose.
• 32:11
  And we actually had a whole segment on this today. And we're doing a lot. So part of what we are
• 32:15
  doing within all of our teachings and our curriculum is we are really creating a standard
• 32:20
  of care pathway of understanding dosing because it's not just what's on the right of thread.
• 32:25
  And I think one of the things that we do really well is we have this, we have this incredible
• 32:28
  faculty. You've all have been different areas of specialty have been using peptide therapy for
• 32:32
  at least a decade or greater in practice. And we were able to proud source them with all of our
• 32:37
  members, which are doctors and clinicians in the field. All the different levels of wherever
• 32:42
  add either just starting. We've been doing it for a while. And we are talking real time about
• 32:46
  different cases, different applications, different dosing strategies. And so just like you could take
• 32:53
  a vitamin or an over the counter something, you have an up to range. Okay. And up to that's really
• 33:00
  how we teach this. It is not a one size fits all or even a one size fits most. And depending on
• 33:05
  for what reason, why are what outcomes are we trying to achieve as a clinician with this
• 33:10
  client or patient and what molecule would then make the most sense and or molecules based on
• 33:17
  where they're at and where we're going to take them to get them that outcome. And when it comes
• 33:21
  to a GLP, you know, again, they are so powerful. It was very easy to bring them to market. Like when
• 33:30
  you look at how the clinical trials were done, they were done appropriately to be able to say at
• 33:35
  scale, how do we get how do we look at patternization, you know, it's got to be real standardized.
• 33:39
  Like to take something a pharmaceutical to market to a doctor and it's at mass, boom,
• 33:43
  boom, boom, boom, boom. And that's that's what they saw. That's what they got. But they didn't
• 33:47
  have studies after that to know now what do we do with the long term effects. What's going on with
• 33:51
  the back side of all the, the, you know, the cacaxia, the circuit being a mess always everything that's
• 33:56
  happening, the all the metabolic, now you can greater metabolic dysfunction, which we'll talk about
• 34:00
  why that is in a moment. And so, but here's the deal. It is now a, that's the main protocol.
• 34:08
  That's the profit model. That's what's driving it. People are doing it. And they want to do it.
• 34:13
  And so the first thing is at first, it's like, yeah, I want to lose weight. But what happens,
• 34:18
  and these are, these are life changing medications. Like, so if you've never, you know,
• 34:23
  your healthy man, you've probably never had to deal with being overweight. You've probably never
• 34:27
  had to deal with any type of body dysmorphia or, or, you know, like obesity or, or clinical
• 34:33
  issues in that regard. But if you've worked with that patient population, if you experience it yourself,
• 34:39
  the, the mental psychology of just the food noise alone that in your head constantly,
• 34:45
  whether it's, I need food, I can't have food. The talk that happens in the head just around
• 34:50
  that phenomena alone. If we just look at that, they are, they are life changing for people that
• 34:56
  have struggle, like true, true struggle. And a managing that you're sowing your head, like,
• 35:02
  life could be the greatest thing. I'm gonna sell out here real quick and tell you, I don't keep
• 35:06
  a secret from it. But I actually was extremely overweight. Yeah. And probably spend most of my
• 35:11
  20s that way until into my 30s to the point that I even when headed up Domino Clasty to remove
• 35:17
  excess skin. Yeah. So no, I do understand. He was like, standards. I do understand
• 35:23
  about it dysmorphia. Yeah. And that's why when I do get to tell it, just the other day, in fact,
• 35:28
  I had a friend of mine call me and say, I need to know what I need to do. I'm going and having
• 35:32
  an abominable plastic because she bought so much weight. And she's like, I literally got
• 35:38
  checked at the airport because they wanted because she had folds of skin. And she's like,
• 35:44
  that was humiliating. Yeah. She's like, and it's been more than once because of the way the skin
• 35:49
  folded from the extreme weight boss. Yeah. That it showed up in a, in a no way, you would have
• 35:53
  really call it here, the millimeter skins or whatever that better than that. And she's like, I
• 35:59
  can't do this. She's like, I wouldn't booked. I'm having a done. And then she calls it's like,
• 36:02
  what should I be doing? What is my pre-care? What is my post-hour? Tell me what this is. And I'm like,
• 36:07
  walk her through the entire thing because first of all, she knows what I do. But she also knows
• 36:12
  I've been there. Yeah. And I'm like, I completely understand that psychology. I've been there,
• 36:17
  done that, got a t-shirt, smaller size. But I'm not smaller size now. But the reality is,
• 36:24
  it's like, no, that's, that's legit. Yeah. Like that body just morphed. Yeah. I've been
• 36:29
  skiing. I've been fat. I've been on both sides of that conversation. And to this day,
• 36:34
  I laughed because I still see myself in that body dysmorphic. Yeah. And so I do understand that.
• 36:42
  And when I look at GLP users, I'm a fan of GLPs because they do understand how
• 36:48
  empowered it is. Yeah. My issue with GLPs is that it's even less from a clinical standpoint
• 36:54
  than it is a cognitive behavioral standpoint. And it is, I'm a big fan of people using GLPs.
• 37:00
  I'm a big fan of it because I look at GLPs as being the pause button while you fix the real
• 37:07
  problem. And that real problem is not, is not way. Correct. The real problem is why the way. Of
• 37:12
  course. And GLPs is an opportunity to put the pause button story if it happened. But I actually
• 37:19
  want to interrupt where you're going with that real quick because we really associate GLPs
• 37:25
  specifically with weight loss because obviously they are, you know, appetite,
• 37:29
  suppressants and gastro, whatever. But I'm actually super interested right now because there's so
• 37:36
  many things that are taking place because of them. I want you to talk through this because GLPs
• 37:41
  are now showing incredible that they actually modify the exact same pleasure center in the brain
• 37:46
  that causes addiction. So we're able to suppress alcohol cravings, gambling,
• 37:53
  it sucks. Where is it getting ready to go? Well, it happens with the food noise.
• 37:56
  They're sorry. It's all good. I teach you there. I love it. But we're noticing now that these GLP
• 38:03
  ones are suppressing their pleasure center. And again, I want to go to good in the bag because
• 38:07
  when we talk about GLPs for weight loss, yeah, I'm a big fan. And not a big fan when the only
• 38:13
  thing you do now is eat a small bag of Doritos and a drink. Correct. Because you've never
• 38:17
  experienced the nutritional product which is leading to hair loss and sarcopenia.
• 38:21
  All of it. And so here's the challenge exactly what you're saying. So if we look at how they came
• 38:27
  to market and how they've been driven by pharma, there's an escalated dose saying it's just higher,
• 38:32
  higher, higher, higher. Unfortunately, this stays active in body five to seven days and it takes
• 38:38
  upwards of four to five weeks to completely metabolize out of the body. So what's happening
• 38:43
  is a dose. It's not just a dose at all. And it's not using the half the way it's we and the
• 38:49
  average person does not understand that the pharmaceutical company doesn't even understand that.
• 38:53
  It's like, Hey, we're going to start to hear. And and then then we're going to take then we're
• 38:57
  going to double you and take you up here. And especially if somebody's on like some a clutide
• 39:00
  or a zempic, there's a high symptom etology profile. Okay. And so they're very uncomfortable for
• 39:05
  people to be on, but they're like, I'd rather be miserable and lose the way them. And they did
• 39:09
  come to market with really the way we all learned because they've been around for 20 years. GLP's
• 39:16
  first came to market 20 years ago. Absolutely. So the same sensitivity. They
• 39:22
  became so popular because of what they did is weight loss. And now wait, here's this new
• 39:28
  phenomena. And like everybody's like, Okay, and now we're getting approved for it. And we can
• 39:32
  actually get, you know, that insurance is going to cover cover some of this. And so, and when you
• 39:37
  have the celebrity speaking, not everything else. So you're right. When it just got dispensed,
• 39:42
  here's script, here's script, here's script. And for the doctor who gets five minutes, who doesn't
• 39:47
  know, and doctors don't have nutrition training. They don't have fitness. They don't have any of that.
• 39:51
  So they're like, Oh, this is the drug and it can help with weight loss. And I've got all these
• 39:55
  patients with type 2 diabetes and metabolic syndrome. And here, here, this works, this works. And
• 40:00
  they're just following the probe call that was shown in the studies. And it's not that it didn't
• 40:05
  work, but they didn't understand how it was working. And so they didn't know what else needed
• 40:12
  to go along with it. And so the doctor doesn't, the, the doctor is out of scope if they sit there
• 40:18
  and try to talk to you about nutrition. Well, a suing, they were people who are getting the
• 40:22
  GOPs or even getting them from a doctor. Sure. But let's just start there. And let's just start
• 40:27
  with, you know, from a kind of where it really began, because so in just traditional realms of
• 40:33
  where it's being first dispensed, but then that education trickles down because it came out so
• 40:38
  quickly. Yeah. So then as the consumer drives and says, I want it. And now all of a sudden the med spa,
• 40:44
  you know, a nurse practitioner mid level that they're, they're able to access it and compound it
• 40:49
  and bring it in and make it available at a lower price, but still have good rice. Now they're
• 40:54
  just like, Okay, we got all these people that want, you know, and so and they don't know either,
• 40:57
  because there wasn't like a roll out of going, Hey, practitioners all over every type. Here's
• 41:03
  this. This is what's coming to market in a really fantastic way. And here's what it does. And here's
• 41:06
  how it works. And if we understand these pathways, then we know if we keep doing this too long,
• 41:10
  this is going to be the downside. So if we really want to stop that, we need to make sure that we
• 41:15
  are doing nutrition at this amount of partying that we're like, but nobody there's like, Oh,
• 41:19
  we have a drug that works in this way, in these pathways and produces weight loss and
• 41:25
  how to use insulin sensitivity or an included bond. And so that's solving a problem. We get a three-year
• 41:30
  patent on it. Let's, let's jam this out of right into the wheels fall off. And then we'll have
• 41:35
  another one come out, um, boom, boom, red is going to be out for 10 years. It's already said they're
• 41:39
  going to make a trillion dollars on that. So it is, there's a bit of it. It started well intention.
• 41:45
  It started. It really did. And then yes, I mean, then that's why we are here again at peptide
• 41:51
  university going, we got to train you guys like you have to understand it. Like guess what?
• 41:55
  There are so many phenomenal benefits. Like GLPs are truly a modern. They are the biggest breakthrough
• 42:01
  in medicine since when I said, well, I agree. And so there are also some of Lutais,
• 42:06
  Emi's most research molecule and medicine of any medicine ever. The amount of money and research.
• 42:12
  Yes. So did not. And so what we're seeing. And again, when I come back to the fact that it's not
• 42:17
  the molecule, it's the dosing. It is the dosing and the misunderstanding of how we escalate it,
• 42:23
  how long we see on and what else we need to do with it. It's the what else we need to do that
• 42:27
  always gets my focus. Because again, it's like you can distribute the molecules. You can do it
• 42:32
  with the dosing. All that stuff matter. If my issue was like no different than weight loss or
• 42:37
  or download plastic, it's like, okay, but what are you doing now? Yeah. Like what are you doing
• 42:42
  now that you've got? Because you've gotten an opportunity to push the pause button and you push
• 42:45
  the pause button. And in the biggest problem that I see, you mentioned start opinion. Yeah,
• 42:51
  because if I'm going to eat something and I'm only eating one thing a day, people are eating
• 42:55
  for pleasure. They're not eating for protein. Right. Like you're not trying to build muscle while
• 42:59
  you're doing this. You're not supplementing. You're trying to lose extreme weight fast. And
• 43:04
  because the pain of hunger has gone away, you've also deprived yourself of nutrition.
• 43:09
  Correct. I get it. It's like we work with them with journalists and whatever. And the biggest
• 43:13
  SKU products that they're searching for for shells are hair loss products for women that are
• 43:19
  on GOPs. And it's like, a GOPs cause hair loss might no malnutrition caused such hair loss.
• 43:25
  Well, GOP, I understand that when you get off of it, you just gain all weight back. Sure.
• 43:29
  If you didn't fix your habits while your appetite was in timeout. Yeah.
• 43:34
  We put your appetite in timeout. Yeah. Did you fix your habits or are you going back to the same
• 43:39
  lifestyle? Yes. You're at the gym more often now because you'd have more energy. Okay. Are you
• 43:44
  keeping up that habit when you're not getting the additional boost? What is going on,
• 43:50
  behaviorally? And I want to ask you probably the most frightening side effect that is now being
• 43:58
  studied because I tend to go to the psychological things of a lot of things. There's a lot of people
• 44:03
  that dance in the physiological space. Probably one of the most frightening things that I'm seeing right
• 44:08
  now, which kind of tracks with what I'm seeing just in patterns and people I know is that people
• 44:16
  who are on GLP ones are now experiencing that same pleasure center that's able to suppress
• 44:21
  addiction or able to suppress gambling or whenever is suppressing intimacy. Oh, yeah.
• 44:27
  That same pleasure center is actually causing people to, if they're saying divorce rates
• 44:32
  amongst GLP users are going up and relationship breakups and people that aren't feeling the
• 44:38
  need to to even express themselves in relationship, whether that's sexual partners or you know,
• 44:45
  just marriages that are completely asexual because they use GLP ones. You just don't feel the
• 44:52
  need for it. Well, yeah. And you're not wrong. And here's a thing like so this comes back to dose.
• 44:57
  So when we when we look at low dose protocols, so there does because again, you do too much of
• 45:03
  anything. What you're doing to these, you know, to these centers, to into these receptor sites,
• 45:10
  you're, you're blunting, you're, you're literally, sorry, held away. You're okay. You know,
• 45:15
  you are overriding that almost physiology. So because of what happened, then because we dose
• 45:19
  them up way too high, we just do the standard protocol. That means we are just going way too high
• 45:24
  for too long. And yeah, we do start to flatten and flatten and flatten and it's again, it's not
• 45:30
  that it is just the GLP. It is a much larger conversation, right? So it is the fact they're doing too
• 45:37
  much. So when we live, one of the one of the assessment questions that a clinician is supposed to
• 45:45
  ask to determine if that patient is appropriate to get on and or stay on, like do we do anything
• 45:52
  with their dose is to look at their appetite. So if there is greater appetite suppression,
• 45:57
  we want them to be at 30 to 50%. If they're more than that, they're on too high a dose. If they're
• 46:02
  less than that, then we haven't gotten them to an effective dose. When we look at 30 to 50%
• 46:08
  because we still want people eating, sure, we want them to eat and we want them to eat what is also
• 46:13
  nutritionally, you know, we want them to have nutrient dense macros in their body. And,
• 46:20
  and the reality is you've just started to take one, like when they're on some of these,
• 46:24
  especially like a, a summer, it's, they are nauseous and they really don't have an appetite and it
• 46:30
  really does become challenging and hard to get it. It's a big appetite, often on for years. Yeah,
• 46:35
  like that's not news, but yeah, that nauseated feeling that people experience. So my point with
• 46:41
  it is that we go too high, we get all that we do get the downsterm is fun for a little while and
• 46:47
  then things start to flatten life, flattens, the food flattens, we're not getting the nutrient
• 46:51
  density, we're not engaging. It's now it's a whole other stream of problems. Okay. And so we
• 46:54
  understand that, you know, to a pretty clear extent, the reality is we're at this really interesting
• 47:00
  precipice right now. And I am seeing the trends even with parma and I work and I sit on advisory
• 47:05
  boards from for some large global companies that are also really taking this conversation forward
• 47:13
  to seeing how long we dose, how low we dose for how long and it's not about trying to keep
• 47:19
  titrating up and up and up. Yeah, that sells more of the drug, but that doesn't mean that that's
• 47:23
  pretty some better results. And so this has been a little bit of the pushback because parma is like,
• 47:27
  no, no, no, no, no, don't say anything about low dose, microdose, like absolutely not,
• 47:31
  because you were not saying that there's more more is better, more is better, no, more is not.
• 47:35
  And so then we think, oh, well, they're just losing weight because the GLP to your point, no,
• 47:40
  they're losing weight because they're malnourished, but if we don't do that high of a dose,
• 47:45
  they don't have to become malnourished. So it can be the best of both worlds. We can be on a low dose,
• 47:49
  we can get all of the anti-inflammatory benefits, we can get all of the insulin sensitivity,
• 47:55
  we can get all the glucose, you know, uptake, you know, enhancement sensitivity,
• 48:01
  benefits from it, we can move into all the longevity benefits from it, cognitive benefits from it,
• 48:06
  the hormonal benefits from it, there are so there's so much data and so many studies coming out
• 48:10
  about lower dose use. And so, you know, really and truly, where a lot of people, where we will
• 48:16
  find ourselves GLPs are not going away, we need to know how to use them better, smarter, and really
• 48:21
  appreciate that it's a tool, but it's only as effective as the environment you're putting it in.
• 48:27
  So do you have the right, it can be a tool, but if you've got a hammer, you don't have the nail,
• 48:31
  and don't have wood, how good is it? Right, so, so we need the right, we need the right nutrition,
• 48:36
  we do need the right movement, right, we do still need about what we started in the beginning,
• 48:41
  we need the right connection and community, like what makes us get up and want to feel the
• 48:45
  neurobodies to begin, but what all of a sudden, yes, I could be blunting my levels for intimacy,
• 48:50
  but what was going on in the bear's before that to begin that we're, you know, we've got deeper human
• 48:54
  issues and the high dosing isn't helping us answer those issues, they're creating more problems.
• 49:00
  I love that you're focusing on high dose, too, because again, if one is good, three is better,
• 49:04
  yeah, my mind's set that the world has and people who have lived in this obese life for too long,
• 49:10
  like they want how to fit, yeah, it gets a fast escape, it's not a slow bleed that actually gets
• 49:15
  them there, and it got an opportunity to do it, and it does cause this overdosing, and I'll say,
• 49:19
  to be GLP one specifically, you're not just talking about people who are on eating and now nourishing,
• 49:24
  or actually the probably the thing that I concerned about, because most people is it's causing this,
• 49:28
  this gastro-backup, people who have such low motility, if you enter intestinal tracks, they,
• 49:34
  they're not realizing that the purpose of elimination is for detox, but you're eliminating toxins
• 49:41
  for your body, well, you go four or five days without a bowel movement, yeah, all that toxicity
• 49:46
  didn't go away, it's just living inside of you still, like your body's becoming a cesspool,
• 49:52
  because you've overdosed your way to the motility, yeah, I'm curious if you could give us some
• 49:59
  tips, you say 13 years younger than your actual age, which I'm calculating to be about 16 now,
• 50:06
  so you're so cute, you're so cute, so 13 years younger, your metabolic age is opposed to
• 50:13
  your chronological age, what tips can I miss you, me, some of that has to deal with peptides,
• 50:19
  and I think a lot of it just has to be with healthy living, to be honest, or even and finding
• 50:23
  purpose in the world, but what recommendations do you man, like our audience watches a podcast
• 50:29
  called the age defiantly, because I believe that there is this, when I hear the word aging,
• 50:33
  it's a very negative connotation, when I hear the word defiantly, it bristles me to fight back
• 50:39
  that native, and in so doing, your aging defiantly. So, well, thank you, I appreciate that,
• 50:47
  you know, years ago, I was on a plane, and this wonderful wise elder was sitting next to me,
• 50:55
  I think she was like 85 at the time, cute little thing, and we were chatting, and I said,
• 51:03
  some time we got talking about age, and she's like, oh my darling, I'm not aging, I'm
• 51:08
  staging, and I'm like, yes, you are, yes you are, yes you are, and so why bring that up, one of my
• 51:15
  first tips, and it is not about a molecule, it's actually about perception, so how we perceive the
• 51:21
  world is how we interpret the world, right, so when I said from the very beginning, like we look at
• 51:25
  inputs, and what's coming into the system, inputs are not just what's on the end of our fork,
• 51:30
  it's not that, it's a piece of it, but literally our perception is our filter of how we see and
• 51:36
  understand and do life, and so do I think that life has happened to me or for me, do I think that
• 51:42
  I'm scared to death to get old to age, because that means I'm going to break down, be decrepit,
• 51:48
  and with my memories, and be put in a home, and be forgotten, or to me, do I view it as staging,
• 51:55
  do I view it as I am getting wiser by the moment, I'm in my, I'm like, you know, Asian like fine wine,
• 52:01
  all those things that I'm a mentor, I'm an elder, I am somebody here that has value, and I
• 52:07
  contribute, so first and foremost, and a lot of the work that we did back in the days with the
• 52:12
  longevity summit, and the coach's longevity book, was, you know, one of my mentors, Dr. Mario
• 52:17
  Martinez, has done the most research, he has met with interviewed the most centenarians on the planet,
• 52:25
  and he said, you know, the mindset that the centenarian holds is they're always looking forward,
• 52:31
  they're not afraid to die today, they'd be a bigger thing, yeah, they expect to live forever,
• 52:37
  but they're not afraid to die today, they're not living with fear, they're not living with regret,
• 52:41
  they're not living with lack, and what I can't, and what I should know my gosh, and guilt and shame,
• 52:45
  and blame and the trauma and the drama, they are curious, you're open, they're flexible,
• 52:50
  they're working forward, I eat around the corner, they understand, I'm like, okay, that happened,
• 52:54
  maybe that's painful, maybe that's uncomfortable, but okay, instead of like, yeah, it's just like,
• 52:59
  oh, I'm witnessing this, this is life, like this is life, and life is the full spactor,
• 53:04
  and it's not just one end of it, it is every shade of gray, like that's what makes it so rich,
• 53:09
  so I believe, and there's a lot of research around this, so just our perception alone,
• 53:13
  we know from multiple studies, and Levy's work is the most pronounced, that we are going to plus
• 53:19
  or minus seven and a half years swing the rate and pace of biological age, so I think I'm ageing,
• 53:26
  and I know that I'm ageless and timeless, and I just look forward to every day, I get up,
• 53:30
  and I was around the corner, let's do this thing, let's go, and I have massive purpose,
• 53:34
  I am driven, I have been forever, and it's not a drive to go hustle and grind, it's like,
• 53:40
  no, I literally, I care about humanity, and also I don't carry humanity, I'm not here to save
• 53:47
  humanity, but I believe in our infinite limitless potential to flourish, like, we are designed
• 53:56
  to be this vibrant expression of aliveness, like we are pure potential, we're pure energy,
• 54:02
  and we're not stagnant, like life is evolution, look at DNA, we're here to evolve,
• 54:06
  we're here to just get better, and better, and better, and better, but we've somehow bought this
• 54:11
  finite story that we're limited, the age is a number, and in a certain time, certain things happen,
• 54:16
  and breakdown is inevitable, and decline is inevitable, and we're like, no, aging is optional,
• 54:20
  so perception is number one, biggest thing, yeah, I love that, okay, and you know, and then it's,
• 54:25
  it really is the most basic things, and I'm sure everybody's like, ah, nobody wants to hear it,
• 54:30
  but honestly, if I had to tell you one of the next things, and this is, and I'm just coming
• 54:35
  into it, like, just, and I'm like, ah, shit, I am working on it, I'm actually being more conscious
• 54:40
  now, because you know, metapause, andropause are real things that when you start to have a change
• 54:47
  in your hormone levels, it does start to change, your circadian biology, circadian rhythms are
• 54:52
  paramount, you want to live a long life well, sleep well, that is where you recover, everybody wants
• 54:58
  to rejuvenate, and inject, and take the other exosomes, and all the things, well guess what,
• 55:03
  if you're not sleep, and you're not repairing, you're not rejuvenating, and regenerating,
• 55:07
  so I love the molecules, but to me, it's like, why am I going to go put something in to a system
• 55:12
  that's already out of it? If my system is not in balance, and I'm not out there to be, you know,
• 55:18
  the Brian Johnson, and that lived to the algorithm, and be so, oh no, like life is beautiful,
• 55:24
  so how do you approach it? To me, I am all, like, moderation, not deprivation, so, you know,
• 55:33
  we went to the table, we'll just get that. There you go, full circle. So, you know, but I think if
• 55:42
  we are looking for some molecules that really do move the needle, I love, so fundamentally,
• 55:47
  like you've got to have your foundational microsomacros, so we've got to be eating just the right
• 55:52
  basic nutrients, or forget the peptides. The peptides don't work if we don't have the terrain.
• 55:57
  One of the things that I'm constantly talking to people about is like, if you're trying to optimize,
• 56:01
  you have to first start from good. You don't get from great from bad, you get to great from good.
• 56:07
  Like, if you're not already 85% of the way out, this last 15, this peptide, that supplementation,
• 56:13
  this biohacking, like, many of it matters if you're depriving yourself proper nutrition,
• 56:18
  proper sleep, and movement. I mean, Mark, here's the thing. We know that 90%. This is World Health
• 56:23
  Organizing. 90% of the population is mineral deficient. 100%. So, we have micronutrient deficiencies
• 56:29
  that express as though there are some type of a chronic disease, oliphate, amylase,
• 56:34
  the inability to repair. And so, again, like, are you getting your right vitamins and minerals
• 56:40
  and nutrients and essential fatty acids and your coq10? Like, are we getting this the basic
• 56:44
  stuff, right? And so, let's assume that we are, right? Let's assume that we are rising with the
• 56:49
  sun, viewing the sun, eating with the sun, moving with the sun, resting with the dark,
• 56:53
  dashing with the dark, recovering with the dark. Let's pretend we're doing that.
• 56:56
  I love that the basics all come back to the same because it doesn't matter who I talk to any
• 57:02
  space. And every time we get to the conversation, I mean, what is it that people should be doing?
• 57:06
  Like, yeah, it all comes back to it. And we're all in our own weird way, experts of the things
• 57:11
  that we talk about and whether device or the supplement or the peptide, whatever it is.
• 57:16
  I love the fact that in this world, all of our answers end up becoming the same. And it's like
• 57:23
  diet, exercise, sleep, do the basics. Like, everything that we're that we're teaching people to do
• 57:32
  is in addition to these things. It's not to request any of these neurons. And I think that's just
• 57:39
  it's balance, right? It's integration. It's healthy relationships. It's it's healthy lifestyle.
• 57:46
  And all of that stuff matters. Then we talk about stem cell treatments. Then they talk about
• 57:52
  all these other names. And I love that you're educating practitioners on this because there's a gap.
• 57:59
  There's a huge gap that exists between what practitioners think they know and what they actually
• 58:03
  know. And it doesn't mean that anybody has it all figured out. You include it. Oh,
• 58:08
  we all have gaps in our knowledge. And we need to be surrounding ourselves in community
• 58:13
  to round out all of the edges that we don't all know. And again, I worry I'm so much just talking
• 58:19
  with people like you even doing this. This is my CEO. Yeah. For sure. For sure.
• 58:23
  I get my continuing education just in talking to people. But I love that so much of that happens.
• 58:29
  We've got such breakthroughs in science right now, such breakthroughs in health, as she said.
• 58:33
  But the DOP is being the next greatest thing to science that the penicillin was.
• 58:38
  I agree with you. And again, like penicillin, use responsibly.
• 58:43
  Correct. Absolutely. Penicillin, we've learned so much about it. Just destroys gut microbiome.
• 58:49
  Incredible discovery. Correct. When used responsibly. And that's really what it comes down to.
• 58:55
  And that's the same thing even for talking about a vitamin or an ur or like there's I can't tell you
• 59:01
  how many times over the years I've gotten in people with side effects of her and her over
• 59:05
  a bite. And like it is like, okay, it really does come down to the system. And I think that
• 59:11
  when we look at any kind of molecule, because it's not just the molecules, what does it do in the
• 59:16
  body? And if I really had to say, how do we age defiantly, it is understanding that
• 59:20
  metabolics are going to accelerate the rate and pace of aging. Okay. So if we are
• 59:27
  leading in chronic stress, physical, mental, emotional, ramacol, environmental, we're overloaded.
• 59:32
  We're not resting. We're not recovering. Right. We're not we're not we're not doing the good
• 59:36
  things where we are aging and breaking down faster than we are repairing and belly back up.
• 59:42
  So when and that and that happens naturally also as we chronologically age. So it is kind of
• 59:48
  this natural progression. So we want to become more mindful of it, which is also why there is so
• 59:52
  there are so many lung gem benefits to low dose and very low dosing of GLPs. Okay. So we're not
• 59:58
  using them for weight loss. We're not doing using them in that memory at all. But to to give support
• 1:00:04
  to these key pathways that can slow down that pace of biological aging. Because that's really
• 1:00:09
  with the rub, right? If you want to age defiantly, it's like, well, how do I not get there's to
• 1:00:14
  the end and breaking down faster? Like, I want to happy, healthy, happy, healthy, happy, healthy.
• 1:00:18
  And then, okay, guess all that should that right? One day, I just want to be done.
• 1:00:22
  Do it. Do it. Do it. You want to go into as fast as I'm always gone into one day.
• 1:00:26
  But that's right. And so it is. And so it's metabonded. And I agree. I'm just being
• 1:00:31
  respectful of time here. The it is fascinating talking to you about this kind of stuff.
• 1:00:35
  Clearly, you know what you're talking about. And I wish everybody had the opportunity to
• 1:00:39
  sit and speak with you. One I want to go through this stuff because there's just such a
• 1:00:43
  saging about you. I think there's an opportunity for people to learn a lot of stuff from you.
• 1:00:50
  And I recommend people follow you on social media, follow your career path and learn more about
• 1:00:55
  how you've gone from longevity into peptides and the movement that you're actually making
• 1:01:01
  globally on this stage where you've got actually international platforms where you're speaking
• 1:01:06
  at places like Davos and all of these other platforms about this phenomenon. Because this
• 1:01:11
  isn't an American thing. This has a global phenomenon in your experience right now. Yeah.
• 1:01:16
  I encourage anybody to follow Melissa Grille Peterson on social media and follow everything that's
• 1:01:22
  going on with peptide university, my peptide university. We'll put everything down in the show
• 1:01:27
  note so that you can follow her learn more about her path. But really everything related to not
• 1:01:33
  just peptide use, but responsible peptide use. And I'm not always layer in there. And the
• 1:01:39
  cognitive behavioral changes that need to take place as supplemental to the peptide use that
• 1:01:45
  peptides are the pause button that we're able to help particularly GLPs to fix the problem. They
• 1:01:51
  aren't the fix to the problem that the fix is much deeper than being able to push that button.
• 1:01:57
  Thank you so much for watching this episode of age to finally with Dr. Melissa. Appreciate
• 1:02:02
  you being here today. Thank you so much for taking the time and we will see you next time.